• Homepage
  • About Arma
  • Sector Expertise
  • Capabilities
  • Global Reach
  • Deals
  • Team
  • Arma Angle
  • News
  • Careers
  • Social Impact
  • Contact

Home / Deals / Advised Nordic Capital on its acquisition of Prospitalia, a leading healthcare-spend management and technology-enabled clinical solutions company and portfolio company of Five Arrows

Advised Nordic Capital on its acquisition of Prospitalia, a leading healthcare-spend management and technology-enabled clinical solutions company and portfolio company of Five Arrows
Jul 2018
acquired
(a portfolio company of Five Arrows)
$725 million
  • Sector: Digital Health
  • Deal Type: Private Equity Deals
  • Engagement type: Buyside
  • Size: $725 million
  • Sector Deals
  • Sector Team
  • Region Deals
Scroll
  • Target Profile
  • Acquirer Profile
  • Deal Rationale
  • Arma Partners' Role

-Prospitalia is a leading healthcare-spend management and technology-enabled clinical solutions company for acute, post-acute and other healthcare service providers and vendors in Germany.

-Founded in 1993 and headquartered in Ulm, Germany, Prospitalia started as a Group Purchasing Organisation for healthcare providers.

-In recent years, the company has tapped into the significant opportunity for technology-enabled clinical solutions.

-The company has almost 200 employees and serves over 3,000 customers in Germany, the UK, the Netherlands and Australia, with an aggregated managed spend of €2.4 billion creating deep and long-standing relationships with healthcare providers as well as suppliers.

-Nordic Capital (“”NC””) focuses on selected regions and sectors where it has deep experience and a proven track record.

-Core sectors are Healthcare, Technology & Payments, Financial Services, Industrial Goods & Services and Consumer & Retail, and key regions are the Nordics, Northern Europe, and globally for Healthcare.

-Since inception in 1989, NC has invested more than €12bn through eight funds.

-Latest fund: Nordic Capital VIII, €3.5bn.

-Healthcare is NC’s most active / successful vertical and they are eager to invest in tech-enabled healthcare

-NC has already invested in 22 companies in the healthcare space, of which 14 have been exited and 8 are still portfolio companies

-The DACH region is also a major focus as they look to expand further in Northern Europe

-Four NC’s healthcare portfolio companies are based in Germany: Ober Scharrer Gruppe, Alloheim, GHD and Sunrise Medical

-Ober Scharrer is a recent acquisition (March 2018) and shares synergies potential with Prospitalia: the company is engaged in providing ophthalmic treatments and medical care to public and private patients

-Arma acted as exclusive financial advisor to NC in the acquisition of Prospitalia from Five Arrows

-The transaction illustrates Arma’s leadership in advising companies in the Healthcare IT sector, leveraging its deep domain expertise and first class execution capabilities

-Arma supported NC with a variety of activities, including:

  • Valuation
  • Views and analysis of potential future acquisition targets
  • Preparation of materials for NC’s investment committee
  • Coordination of due diligence
  • Management of VDR and Q&A
  • Transaction negotiations, strategy and structuring

– This transaction highlights Arma’s long-standing track record of working with private equity clients to secure successful cross border deals

Back to deals
Arma Partners logo
  • About Arma
  • Sector Expertise
  • Capabilities
  • Global Reach
  • Deals
  • Team
  • Arma Angle
  • News
  • Careers
  • Social Impact
  • Contact

Arma Partners LLP is authorised and regulated by the Financial Conduct Authority and registered as a limited liability partnership in England and Wales (registered number OC307424. VAT registered number 162087808).

  • Privacy Notice
  • Terms & Conditions of Use
  • Modern Slavery Act Statement
  • Sustainability
  • Sitemap

US Arma Partners LP is a FINRA member.

You can check the background of US Arma Partners LP and its registered representatives on FINRA’s BrokerCheck.

Copyright © 2022 Arma Partners Site produced by Skylark

We at Arma Partners are committed to respecting your privacy and protecting your personal data. This privacy notice will inform you as to how we look after your personal data when you visit our website (regardless of where you visit it from) and tell you about your privacy rights and how the law protects you.
Learn More Accept Cookies